FONDAPARINUX
Deep Venous Thrombosis
Johns Hopkins UniversitySmall moleculeEarly Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Deep Venous Thrombosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Enoxaparin University Of Perugia | Phase 3 | BBB |
WARFARIN Massachusetts General Hospital | Phase 3 | BB |
HEPARIN Johns Hopkins University | Phase 4 | B |
Same molecule, other indications
FONDAPARINUX is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →